News stories about MedEquities Realty Trust (NYSE:MRT) have been trending positive on Wednesday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MedEquities Realty Trust earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.3986510217096 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:
Several research firms recently commented on MRT. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $11.00 price objective (down from $12.00) on shares of MedEquities Realty Trust in a research report on Wednesday. B. Riley set a $13.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research report on Monday, May 14th. JMP Securities set a $13.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research report on Friday, May 11th. ValuEngine cut shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Finally, KeyCorp cut their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Monday, April 16th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $12.25.
MRT opened at $10.30 on Wednesday. The firm has a market capitalization of $328.11 million, a P/E ratio of 9.04 and a beta of -0.18. MedEquities Realty Trust has a 12 month low of $9.67 and a 12 month high of $13.06.
MedEquities Realty Trust (NYSE:MRT) last issued its quarterly earnings results on Thursday, May 10th. The financial services provider reported $0.16 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.14). MedEquities Realty Trust had a return on equity of 6.17% and a net margin of 34.63%. The business had revenue of $16.72 million for the quarter, compared to the consensus estimate of $16.41 million. equities analysts predict that MedEquities Realty Trust will post 1.2 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 5th. Shareholders of record on Tuesday, May 22nd will be given a dividend of $0.21 per share. The ex-dividend date is Monday, May 21st. This represents a $0.84 annualized dividend and a yield of 8.16%. MedEquities Realty Trust’s dividend payout ratio (DPR) is presently 73.68%.
In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 17,674 shares of the business’s stock in a transaction dated Friday, May 4th. The shares were sold at an average price of $10.16, for a total transaction of $179,567.84. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have sold a total of 313,452 shares of company stock worth $3,239,316 over the last three months. Insiders own 3.00% of the company’s stock.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.